Publications in collaboration with researchers from Fundación Hospital Alcorcón (4)

2019

  1. Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study

    Breast Journal, Vol. 25, Núm. 2, pp. 219-225

2018

  1. Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer

    European Respiratory Journal

2016

  1. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients

    Journal of Gynecologic Oncology, Vol. 27, Núm. 1

2015

  1. Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients

    Molecular Oncology, Vol. 9, Núm. 2, pp. 422-436